Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Testosterone Gel 1.62% in Hypogonadal Men
NCT00433199Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Feb 2007
- Primary completion
- Oct 2007
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of AndroForte in Hypogonadism, sponsored by Abbott Laboratories. Started Feb 2007; status: completed.
02
Drugs
AndroForte
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT00433199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00433199.